BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 34765932)

  • 1. Evaluation of point of care serum cryptococcal antigen by lateral flow immunoassay for diagnosis of cryptococcosis and cryptococcal meningitis in HIV-positive patients.
    Kamble U; Dheeresh KH; Bhosale K; Indu MB; Sharma B; Chowdhary A
    Indian J Sex Transm Dis AIDS; 2021; 42(1):14-18. PubMed ID: 34765932
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Accuracy of Point of Care Cryptococcal Antigen Lateral Flow Assay in Fingerprick Whole Blood and Urine Samples for the Detection of Asymptomatic Cryptococcal Disease in Patients with Advanced HIV Disease.
    Boyd K; Kouamou V; Hlupeni A; Tangwena Z; Ndhlovu CE; Makadzange AT;
    Microbiol Spectr; 2022 Aug; 10(4):e0107522. PubMed ID: 35924841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of cryptococcal antigen lateral flow assay in serum, cerebrospinal fluid, whole blood, and urine in HIV-infected patients with culture-proven cryptococcal meningitis admitted at a Brazilian referral center.
    Vidal JE; Toniolo C; Paulino A; Colombo AL; Martins MDA; Meira CDS; Azevedo RGS; Pereira-Chioccola VL; Gomes HR; Lazera MDS; Oliveira ACP; Boulware DR
    Rev Inst Med Trop Sao Paulo; 2018; 60():e1. PubMed ID: 29451598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITY.
    Vidal JE; Boulware DR
    Rev Inst Med Trop Sao Paulo; 2015 Sep; 57 Suppl 19(Suppl 19):38-45. PubMed ID: 26465368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a Cryptococcus capsular polysaccharide detection FungiXpert LFA (lateral flow assay) for the rapid diagnosis of Cryptococcosis.
    Liu Y; Kang M; Wu SY; Wu LJ; He L; Xiao YL; Zhang WL; Liao QF; Deng J; Chen ZX; Ma Y
    Med Mycol; 2022 Apr; 60(4):. PubMed ID: 35362524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis and budgetary impact of the Cryptococcal Antigen Lateral Flow Assay (CRAG-LFA) implementation for the screening and diagnosis of cryptococcosis in asymptomatic people living with HIV in Brazil.
    Vianna CMM; Mosegui GBG
    Rev Inst Med Trop Sao Paulo; 2021; 63():e57. PubMed ID: 34231822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of fingerstick cryptococcal antigen lateral flow assay in HIV-infected persons: a diagnostic accuracy study.
    Williams DA; Kiiza T; Kwizera R; Kiggundu R; Velamakanni S; Meya DB; Rhein J; Boulware DR
    Clin Infect Dis; 2015 Aug; 61(3):464-7. PubMed ID: 25838287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multisite validation of cryptococcal antigen lateral flow assay and quantification by laser thermal contrast.
    Boulware DR; Rolfes MA; Rajasingham R; von Hohenberg M; Qin Z; Taseera K; Schutz C; Kwizera R; Butler EK; Meintjes G; Muzoora C; Bischof JC; Meya DB
    Emerg Infect Dis; 2014 Jan; 20(1):45-53. PubMed ID: 24378231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Diagnostic Performance of a Semiquantitative Cryptococcal Antigen Point-of-Care Assay among HIV-Infected Persons with Cryptococcal Meningitis.
    Tadeo KK; Nimwesiga A; Kwizera R; Apeduno L; Martyn E; Okirwoth M; Nalintya E; Rajasingham R; Williams DA; Rhein J; Meya DB; Kafufu B; Boulware DR; Skipper CP
    J Clin Microbiol; 2021 Jul; 59(8):e0086021. PubMed ID: 34076472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the Dynamiker Cryptococcal Antigen Lateral Flow Assay for the Diagnosis of HIV-Associated Cryptococcosis.
    Kwizera R; Omali D; Tadeo K; Kasibante J; Rutakingirwa MK; Kagimu E; Ssebambulidde K; Williams DA; Rhein J; Boulware D; Meya DB
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33268538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.
    Frola C; Guelfand L; Blugerman G; Szyld E; Kaufman S; Cahn P; Sued O; Pérez H
    PLoS One; 2017; 12(6):e0178721. PubMed ID: 28617817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cryptococcal antigen prevalence in HIV-infected Tanzanians: a cross-sectional study and evaluation of a point-of-care lateral flow assay.
    Rugemalila J; Maro VP; Kapanda G; Ndaro AJ; Jarvis JN
    Trop Med Int Health; 2013 Sep; 18(9):1075-1079. PubMed ID: 23937699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness Analysis of the Implementation of Cryptococcal Antigen Lateral Flow Assay for the Diagnosis of Cryptococcal Meningitis in Symptomatic People Living With Human Immunodeficiency Virus in Brazil.
    Vianna CMM; Mosegui GBG
    Value Health Reg Issues; 2022 May; 29():53-59. PubMed ID: 34801886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of low cryptococcal antigen titer as determined by the lateral flow assay in serum and cerebrospinal fluid among HIV-negative patients: a retrospective diagnostic accuracy study.
    Wang X; Cheng JH; Zhou LH; Zhu JH; Wang RY; Zhao HZ; Jiang YK; Huang LP; Yip CW; Que CX; Zhu M; Zhu LP
    IMA Fungus; 2020; 11():6. PubMed ID: 32617257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a point-of-care immunoassay test kit 'StrongStep' for cryptococcal antigen detection.
    Mpoza E; Mukaremera L; Kundura DA; Akampurira A; Luggya T; Tadeo KK; Pastick KA; Bridge SC; Tugume L; Kiggundu R; Musubire AK; Williams DA; Muzoora C; Nalintya E; Rajasingham R; Rhein J; Boulware DR; Meya DB; Abassi M
    PLoS One; 2018; 13(1):e0190652. PubMed ID: 29304090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cryptococcal Antigen Screening in Patients Initiating ART in South Africa: A Prospective Cohort Study.
    Longley N; Jarvis JN; Meintjes G; Boulle A; Cross A; Kelly N; Govender NP; Bekker LG; Wood R; Harrison TS
    Clin Infect Dis; 2016 Mar; 62(5):581-587. PubMed ID: 26565007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Cryptococcus antigen in human immunodeficiency virus-positive Turkish patients by using the Dynamiker
    Karaman E; Ilkit M; Kuşçu F
    Mycoses; 2019 Oct; 62(10):961-968. PubMed ID: 31344286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of central nervous system cryptococcosis using a fingerprick whole-blood lateral flow assay in individuals with neurological symptoms and advanced HIV disease in a Brazilian emergency department.
    Oliveira FG; Nakagawa JAS; de Oliveira JMM; Júnior RML; Marcusso R; Vidal JE
    Med Mycol; 2023 Sep; 61(9):. PubMed ID: 37656871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Performance of the Lateral Flow Assay and the Latex Agglutination Serum Cryptococcal Antigen Test in Cryptococcal Disease in Patients with and without HIV.
    Hevey MA; George IA; Rauseo AM; Larson L; Powderly W; Spec A
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32848037
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Asymptomatic cryptococcal antigen prevalence detected by lateral flow assay in hospitalised HIV-infected patients in São Paulo, Brazil.
    Vidal JE; Toniolo C; Paulino A; Colombo A; Dos Anjos Martins M; da Silva Meira C; Pereira-Chioccola VL; Figueiredo-Mello C; Barros T; Duarte J; Fonseca F; Alves Cunha M; Mendes C; Ribero T; Dos Santos Lazera M; Rajasingham R; Boulware DR
    Trop Med Int Health; 2016 Dec; 21(12):1539-1544. PubMed ID: 27699970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.